|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2504364 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10833923.5 |
| Date of filing the European patent application | 2010-11-24 | |
| (97) | Date of publication of the European application | 2012-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-09 |
| (46) | Date of publication of the claims translation | 2017-11-10 |
| (86) | Number | PCT/US2010/058007 |
| Date | 2010-11-24 |
| (87) | Number | WO 2011/066389 |
| Date | 2011-06-03 |
| (30) | Number | Date | Country code |
| 264061 P | 2009-11-24 | US |
| (72) |
QUEVA, Christophe, US
MORROW, Michelle, GB
HAMMOND, Scott, US
ALIMZHANOV, Marat, US
BABCOOK, John, CA
FOLTZ, Ian, CA
KANG, Jaspal, Singh, CA
SEKIROV, Laura, CA
BOYLE, Melanie, GB
CHODORGE, Matthieu, GB
MULGREW, Kathleen Ann, US
STEWART, Ross, GB
|
| (73) |
Medimmune Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 OAA,
GB
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Tiksliniai surišantys agentai prieš B7-H1 |
| TARGETED BINDING AGENTS AGAINST B7-H1 |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 16 | 347.00 EUR |
| 2026-11-24 |